C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 239/94 (2006.01) C07D 401/04 (2006.01) C07D 401/06 (2006.01) C07D 401/12 (2006.01) C07D 401/14 (2006.01) C07D 403/04 (2006.01) C07D 403/06 (2006.01) C07D 403/10 (2006.01) C07D 403/12 (2006.01) C07D 403/14 (2006.01) C07D 405/04 (2006.01) C07D 405/12 (2006.01) C07D 405/14 (2006.01) C07D 409/12 (2006.01) C07D 413/04 (2006.01) C07D 413/12 (2006.01)
Patent
CA 2648529
The invention provides quinazoline compounds that are inhibitors of PDKl. Also provided are pharmaceutical compositions including the compounds, and methods of treating proliferative diseases, such as cancers, with the compounds or compositions.
La présente invention concerne de nouveaux composés de quinazoline qui sont des inhibiteurs de PDK1. L'invention a également trait à des compositions pharmaceutiques comprenant ces composés ainsi qu'à des procédés de traitement des maladies prolifératives, telles que les cancers, par lesdits composés ou compositions.
Aikawa Mina
Amiri Payman
Basham Steven E.
Jain Rama
Jansen Johanna M.
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Quinazolines for pdk1 inhibition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinazolines for pdk1 inhibition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinazolines for pdk1 inhibition will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1700176